Reuters

The spray, designed by Australian group Acrux Ltd. and being developed by U.S.-based Vivus Inc., has previously worked on women who have passed menopause, who typically have low testosterone.
However, investigators said the company may be able to win approval for its product more easily by targeting young women, where the spray would take testosterone back to normal levels.

More...

Takeover of Indigenous Garifuna Community Hospital

Menstruation Is Fast Becoming Optional

Rare Disease Traced to Sperm Donor

Crohn's Disease Drug Cleared for Children

5-Month-Old Girls in ICU After Separation

Coroner: Peanut Kiss Didn't Cause Death

Feds Probe Kidney Transplant Program

Supermarkets Urge Families to Dinner Table